VANDA Pharmaceuticals - Investor Relations - IR Home

Investor Relations

IR Home

IR Home

Stock Chart

Copyright West LLC. Minimum 15 minutes delayed.

Primary IR Contact

For members of the press or investor community who wish to obtain more information about Vanda, please contact
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals, Inc.
(202) 734-3428

Copyright Ā© 2005-2019 Vanda Pharmaceuticals Inc. |